Laughlin Family Foundation for Rare Cancers

Analysis

Laughlin Family Foundation for Rare Cancers is a registered charity in United States, based in Crofton, MD. It received its IRS tax-exemption ruling in February 2019, 7 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Laughlin Family Foundation for Rare Cancers reported income of $253k and spending of $290k, spending 115% of what it took in. Across the 4 years on record, from December 2020 to December 2023, income grew from $157k to $253k (+61%), an average of +17% a year. The sharpest change came in the year to December 2022, when income rose by 43%. Over the whole period it spent 74% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Laughlin Family Foundation for Rare Cancers sits at the 44th percentile: it is larger than about 44% of them. Against every charity in United States with reported income it ranks in the 58th percentile, and in the 58th percentile within MD. Charities of a similar size with the same main cause include Mount Sinai Hospital Foundation Inc ($252k), Pacific Northwest Gastroenterology Society ($253k) and Outreach Center of West Houston ($252k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 59% of the total. Compensation of current officers, directors and key employees was $96k (33% of expenses). At year end it held assets of $209k against liabilities of $0, net assets of $209k.